TauRx to Present at Jefferies 2010 Global Life Sciences Conference

Prof Claude Wischik, Executive Chairman of TauRx Pharmaceuticals Ltd will provide a corporate summary and updates on TauRx's clinical program for disease modifying                 agents for Alzheimer's disease at the Jefferies Conference. Professor Wischik will also review the company's recently announced diagnostic collaboration with Bayer Schering Pharma, the potential of a diagnostic to improve the management of Alzheimer's disease and also its potential supporting role in disease prevention. The presentation will be given at the Jefferies 2010 Global Life Sciences Conference in New York on June 9th, 2010 at 4:30 p.m. Eastern Time.